Breast Cancer

“My stories are my trail of crumbs leading back to my heart and my innermost thoughts,” writes a woman living with metastatic breast cancer.

A patient reflects on the comfort and grief within the world of metastatic breast cancer.

A modeling study demonstrated that breast cancer mortality may increase by 0.52% by 2030, but effects of delays during the COVID-19 pandemic may be mitigated by making up screenings sooner than later.

A hard-charging executive felt lost after surviving cancer because she didn’t fit into her old life. But, she says, “cancer changed my life, so I changed my world.”

African American women with benign ethnic neutropenia had clinical benefit with Ibrance (palbociclib) in combination with endocrine therapy to treat advanced breast cancer.

There is no need for concern of breast cancer for women using fertility drugs to become pregnant, according to recent research.

A woman who underwent surgery for breast cancer shares a transformative experience in which she posed for a photographer who documented her mastectomy scars.

From Ina Jaffe’s breast cancer news to a couple moving up their wedding due to a cancer diagnosis, here’s what’s happening in the cancer landscape this week.

Many women with breast cancer choose to undergo reconstruction after mastectomy. Of those women, some opt for nipple sparing surgeries while others do not. “Those who choose to save their nipples are often disappointed when the tissue dies or no longer functions as it did before surgery,” writes one survivor. “But why are nipples so important?”

Recent research found that breast implants with a specific texture tended to result in a lower level of inflammation and immune reactions than other implants.

The survival benefit obtained with Ibrance plus Faslodex persisted over a median follow-up of 73.3 months in patients with HR-positive, HER2-negative advanced breast cancer.

A man with breast cancer recalls his introduction to cancer as a child.

Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.

Latasha Jordan, a triple-negative breast cancer survivor, discusses challenges she faced with her symptoms and diagnosis, and Aditya Bardia, M.D., MPH, reviews the typical diagnostic work-up used to determine a treatment approach.

“All women with breast cancer deserve quality health care,” writes one survivor. “But for an incarcerated woman, that care may not come in a timely manner, if at all.”

From an emotional "America’s Got Talent” audition from a singer with cancer to a wig company that creates wigs for women of color, here’s what’s happening in the cancer landscape this week.

The data, according to the study’s lead author, confirm that Trodelvy should be considered a new standard of care in patients with metastatic triple-negative breast cancer.

Patients with early triple-negative breast cancer receiving Imfinzi in addition to neoadjuvant chemotherapy saw increased survival rates and complete responses to treatment.

Some patients with early HER2-negative breast cancer at high risk for disease recurrence achieved meaningful benefit with Lynparza after receiving standard of care therapies, such as surgery or chemotherapy.

A patient with metastatic breast cancer describes how the right words can offer hope to patients and the wrong ones can haunt them forever.

In this episode of the “CURE® Talks Cancer” podcast, breast cancer survivor Tomika Bryant discusses her cancer journey, advocacy work and how blogging helped her get through treatment.

“Understanding and taking action against racial differences in cancer care and clinical trial participation are made more powerful when we listen to patient voices,” writes one patient with breast cancer.

The effectiveness of the Pfizer-BioNTech COVID-19 vaccine increased significantly among patients with cancer who received a vaccine booster 21 days after receiving the first dose.

Consuming even one sugar-sweetened drink per day such as soda, fruit-flavored drinks, energy drinks, punches and sports drinks after a breast cancer diagnosis could increase the risk of mortality.

A diagnosis of diabetes, high blood pressure or cardiovascular disease within two years of being diagnosed with breast cancer impacted a woman’s risk for death related to breast cancer or cardiovascular disease.